Invention Grant
- Patent Title: Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate
-
Application No.: US13988072Application Date: 2011-11-18
-
Publication No.: US10857102B2Publication Date: 2020-12-08
- Inventor: Reza Oliyai , Lauren Wiser , Mark Menning
- Applicant: Reza Oliyai , Lauren Wiser , Mark Menning
- Applicant Address: US CA Foster City IE Little Island
- Assignee: Gilead Sciences, Inc.,Janssen Sciences Ireland UC
- Current Assignee: Gilead Sciences, Inc.,Janssen Sciences Ireland UC
- Current Assignee Address: US CA Foster City IE Little Island
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2011/061515 WO 20111118
- International Announcement: WO2012/068535 WO 20120524
- Main IPC: A61K31/505
- IPC: A61K31/505 ; A61K31/513 ; A61K31/675 ; A61K9/24
Abstract:
The invention provides multilayer tablets that contain rilpivirine hydrochloride, emtricitabine, and tenofivir disoproxil fumarate. The tablets are useful for the treatment of HIV.
Public/Granted literature
- US20130243857A1 THERAPEUTIC COMPOSITIONS COMPRISING RILPIVIRINE HCL AND TENOFOVIR DISOPROXIL FUMARATE Public/Granted day:2013-09-19
Information query
